| Original language | English (US) |
|---|---|
| Pages (from-to) | e69 |
| Journal | The Lancet Oncology |
| Volume | 20 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2019 |
Bibliographical note
Funding Information:TM reports research funding from the Canadian Institutes of Health Research (CIHR) during the conduct of the study. ELF reports research funding from CIHR during the conduct of the study; grants from Merck, grants and non-financial support from Roche, personal fees from Merck, and personal fees from GlaxoSmithKline outside of the submitted work. SK declares no competing interest.